Clinical Use of Growth Factors in the Improvement of Skin Wound Healing


To discuss the normal mechanism of wound healing (WH), the role of growth factors (GF) in prec-linical and clinical studies and its importance in the healing of abnormal wound therapy. For search, we used the PUBMED and LILACS database, and the following descriptors: skin, wound healing, growth factor and clinical trials. We also prioritized the analysis of the Clinical Trials in the previous 10 years. Although there are many studies being conducted in the pre-clinical phase, we see that there are few studies in the clinical phase. 274 studies were identified, and 58 were selected. After tissue injury, repair occurs through coordinated biological actions that are healing. The importance of the study of healing in the skin is not only because of its anatomical location, easy access and exposure, but also because of its vital function. There is accumulating evidence that the process of healing after injury may be mediated by several GF. However, may this class of molecules even act effectively on the clinical response of this pathological condition? Many preclinical studies (in vitro and in vivo) reinforce the importance and efficacy of GF in the regeneration of damaged skin. Furthermore, recent studies have reported the use in adjuvant or not, of GF in clinical treatment to improve WH in humans. Therefore, we conclude that it seems to be effective by the use of GF in adjuvant or not in WH. However, it still seems to be necessary to carry out more clinical trials in phase I and II.

Share and Cite:

Mac Cornick, S. , de Noronha, S. , Chominski, V. , de Noronha, S. , Ferreira, L. and Gragnani, A. (2014) Clinical Use of Growth Factors in the Improvement of Skin Wound Healing. Open Journal of Clinical Diagnostics, 4, 227-236. doi: 10.4236/ojcd.2014.44032.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Rojas, Y., Finnerty, C.C., Radhakrishnan, R.S. and Herndon, D.N. (2012) Burns: An Update on Current Pharmacotherapy. Expert Opinion on Pharmacotherapy, 13, 2485-2494.
[2] Zhao, G., Usui, M.L., Lippman, S.I., James, G.A., Stewart, P.S., Fleckman, P. and Olerud, J.E. (2013) Biofilms and Inflammation in Chronic Wounds. Advances in Wound Care (New Rochelle), 2, 389-399.
[3] Sinno, H. and Prakash, S. (2013) Complements and the Wound Healing Cascade: An Updated Review. Plastic Surgery International, 2013, Article ID: 146764, 7 p.
[4] Sánchez, M., Anitua, E., Orive, G., Mujika, I. and Andia, I. (2009) Platelet-Rich Therapies in the Treatment of Orthopaedic Sport Injuries. Sports Medicine, 39, 345-354.
[5] Kuebler, U., Wirtz, P.H., Sakai, M., Stemmer, A. and Ehlert, U. (2013) Acute Stress Reduces Wound-Induced Activation of Microbicidal Potential of ex Vivo Isolated Human Monocyte-Derived Macrophages. PLoS One, 8, e55875.
[6] Peplow, P.V. and Chatterjee, M.P. (2013) A Review of the Influence of Growth Factors and Cytokines in in Vitro Human Keratinocyte Migration. Cytokine, 62, 1-21.
[7] Uutela, M., Wirzenius, M., Paavonen, K., Rajantie, I., He, Y., Karpanen, T., Lohela, M., Wiig, H., Salven, P., Pajusola, K., Eriksson, U. and Alitalo, K. (2004) PDGF-D Induces Macrophage Recruitment, Increased Interstitial Pressure, and Blood Vessel Maturation during Angiogenesis. Blood, 104, 3198-3204.
[8] Hoeben, A., Landuyt, B., Highley, M.S., Wildiers, H., Van Oosterom, A.T. and De Bruijn, E.A. (2004) Vascular Endothelial Growth Factor and Angiogenesis. Pharmacological Reviews, 56, 549-580.
[9] Yoo, S.Y. and Kwon, S.M. (2013) Angiogenesis and Its Therapeutic Opportunities. Mediators of Inflammation, 2013, Article ID 127170, 11 p.
[10] Eppley, B.L., Woodell, J.E. and Higgins, J. (2004) Platelet Quantification and Growth Factor Analysis from Platelet-Rich Plasma: Implications for Wound Healing. Plastic and Reconstructive Surgery, 114, 1502-1508.
[11] Riedel, K., Riedel, F., Goessler, U.R., Germann, G. and Sauerbier, M. (2007) TGF-β Antisense Therapy Increases Angiogenic Potential in Human Keratinocytes in Vitro. Archives of Medical Research, 38, 45-51.
[12] Broughton II, G., Janis, J.E. and Attinger, C.E. (2006) The Basic Science of Wound Healing. Plastic & Reconstructive Surgery, 117, 12S-34S.
[13] Chambers, R.C. (2008) Procoagulant Signalling Mechanisms in Lung Inflammation and Fibrosis: Novel Opportunities for Pharmacological Intervention? British Journal of Pharmacology, 153, S367-S378.
[14] Verhaegen, P.D., van Zuijlen, P.P., Pennings, N.M., van Marle, J., Niessen, F.B., van der Horst, C.M. and Middelkoop, E. (2009) Differences in Collagen Architecture between Keloid, Hypertrophic Scar, Normotrophic Scar, and Normal Skin: An Objective Histopathological Analysis. Wound Repair and Regeneration, 17, 649-656.
[15] Greenhalgh, D.G. (2005) Models of Wound Healing. Journal of Burn Care & Rehabilitation, 26, 293-305.
[16] Vande Berg, J.S., Rose, M.A., Haywood-Reid, P.L., Rudolph, R., Payne, W.G. and Robson, M.C. (2005) Cultured Pressure ulcer Fibroblasts Show Replicative Senescence with Elevated Production of Plasmin, Plasminogen Activator Inhibitor-1, and Transforming Growth Factor-Beta1. Wound Repair and Regeneration, 13, 76-83.
[17] Aspenberg, P. and Virchenko, O. (2004) Platelet Concentrate Injection Improves Achilles Tendon Repair in Rats. Acta Orthopaedica, 75, 93-99.
[18] Mishra, A., Harmon, K., Woodall, J. and Vieira, A. (2011) Sports Medicine Applications of Platelet Rich Plasma. Current Pharmaceutical Biotechnology, 13, 1185-1195.
[19] Boo, S. and Dagnino, L. (2013) Integrins as Modulators of Transforming Growth Factor Beta Signaling in Dermal Fibroblasts during Skin Regeneration after Injury. Advances in Wound Care (New Rochelle), 2, 238-246.
[20] Zheng, Z., Kang, H.Y., Lee, S., Kang, S.W., Goo, B. and Cho, S.B. (2014) Upregulation of Fibroblast Growth Factor (FGF) 9 Expression and FGF-WNT/β-Catenin Signaling in Laser-Inducedwound Healing. Wound Repair and Regeneration, 22, 660-665.
[21] Chrissouli, S., Pratsinis, H., Velissariou, V., Anastasiou, A. and Kletsas, D. (2010) Human Amniotic Fluid Stimulates the Proliferation of Human Fetal and Adult Skin Fibroblasts: The Roles of bFGF and PDGF and of the ERK and Akt Signaling Pathways. Wound Repair and Regeneration, 18, 643-654.
[22] Akita, S., Akino, K., Imaizumi, T. and Hirano, A. (2008) Basic Fibroblast Growth Factor Accelerates and Improves Second-Degree Burn Wound Healing. Wound Repair and Regeneration, 16, 635-641.
[23] Ma, B., Cheng, D.S., Xia, Z.F., Ben, D.F., Lu, W., Cao, Z.F., et al. (2007) Randomized, Multicenter, Double-Blind, and Placebo-Controlled Trial Using Topical Recombinant Human Acidic Fibroblast Growth Factor for Deep Partial- Thickness Burns and Skin Graft Donor Site. Wound Repair and Regeneration, 15, 795-799.
[24] Bao, S., Wang, Y., Sweeney, P., Chaudhuri, A., Doseff, A.I., Marsh, C.B. and Knoell, D.L. (2005) Keratinocyte Growth Factor Induces Akt Kinase Activity and Inhibits Fas-Mediated Apoptosis in A549 Lung Epithelial Cells. American Journal of Physiology-Lung Cellular and Molecular Physiology, 288, L36-L42.
[25] Koivisto, L., Jiang, G., Hakkinen, L., Chan, B. and Larjava, H. (2006) HaCaT Keratinocyte Migration Is Dependent on Epidermal Growth Factor Receptor Signaling and Glycogen Synthase Kinase-3α. Experimental Cell Research, 312, 2791-2805.
[26] Gomperts, B.N., Belperio, J.A., Fishbein, M.C., Keane, M.P., Burdick, M.D. and Strieter, R.M. (2007) Keratinocyte Growth Factor Improves Repair in the Injured Tracheal Epithelium. American Journal of Respiratory Cell and Molecular Biology, 37, 48-56.
[27] Alemdaroglu, C., Degim, Z., Celebi, N., Zor, F., Ozturk, S. and Erdogan, D. (2006) An Investigation on Burn Wound Healing in Rats with Chitosan Gel Formulation Containing Epidermal Growth Factor. Burns, 32, 319-327.
[28] Alemdaroglu, C., Degim, Z., Celebi, N., Sengezer, M., Alomeroglu, M. and Nacar, A. (2008) Investigation of Epidermal Growth Factor Containing Liposome Formulation Effects on Burn Wound Healing. Journal of Biomedical Materials Research Part A, 85, 271-283.
[29] Jahovic, N., Guzel, E., Arbak, S. and Yegen, B.C. (2004) The Healing-Promoting Effect of Saliva on Skin Burn Is Mediated by Epidermal Growth Factor (EGF): Role of the Neutrophils. Burns, 30, 531-538.
[30] Barrientos, S., Stojadinovic, O., Golinko, M.S., Brem, H. and Tomic-Canic, M. (2008) Growth Factors and Cytokines in Wound Healing. Wound Repair and Regeneration, 16, 585-601.
[31] Infanger, M., Schmidt, O., Kossmehl, P., Grad, S., Ertel, W. and Grimm, D. (2004) Vascular Endothelial Growth Factor Serum Level Is Strongly Enhanced after Burn Injury and Correlated with Local and General Tissue Edema. Burns, 30, 305-311.
[32] Bao, P., Kodra, A., Tomic-Canic, M., Golinko, M.S., Ehrlich, H.P. and Brem, H. (2009) The Role of Vascular Endothelial Growth Factor in Wound Healing. Journal of Surgical Research, 153, 347-358.
[33] Garovic, V.D., Wagner, S.J., Petrovic, L.M., Gray, C.E., Hall, P., Sugimoto, H., et al. (2007) Glomerular Expression of Nephrin and Synaptopodin, but Not Podocin, Is Decreased in Kidney Sections from Women with Preeclampsia. Nephrology Dialysis Transplantation, 22, 1136-1143.
[34] Nagy, J.A., Chang, S.H., Shih, S.C., Dvorak, A.M. and Dvorak, H.F. (2010) Heterogeneity of the Tumor Vasculature. Seminars in Thrombosis and Hemostasis, 36, 321-331.
[35] Eming, S.A. and Krieg, T. (2006) Molecular Mechanisms of VEGF-A Action during Tissue Repair. Journal of Investi- gative Dermatology Symposium Proceedings, 11, 79-86.
[36] Shen, F., Su, H., Fan, Y., Chen, Y., Zhu, Y., Liu, W., Young, W.L. and Yang, G.Y. (2006) Adeno-Associated Viral- Vector-Mediated Hypoxia-Inducible Vascular Endothelial Growth Factor Gene Expression Attenuates Ischemic Brain Injury after Focal Cerebral Ischemia in Mice. Stroke, 37, 2601-2606.
[37] Chen, J.C., Lin, B.B., Hu, H.W., Lin, C., Jin, W.Y., Zhang, F.B., Zhu, Y.A., Lu, C.J., Wei, X.J. and Chen, R.J. (2014) NGF Accelerates Cutaneous Wound Healing by Promoting the Migration of Dermal Fibroblasts via the PI3K/Akt-Rac1-JNK and ERK Pathways. BioMed Research International, 2014, Article ID: 547187.
[38] Palazzo, E., Marconi, A., Truzzi, F., Dallaglio, K., Petrachi, T., Humbert, P., Schnebert, S., Perrier, E., Dumas, M. and Pincelli, C. (2012) Role of Neurotrophins on Dermal Fibroblast Survival and Differentiation. Journal of Cellular Physiology, 227, 1017-1025.
[39] Pakyari, M., Farrokhi, A., Maharlooei, M.K. and Ghahary, A. (2013) Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing. Advances in Wound Care (New Rochelle), 2, 215-224.
[40] Finnson, K.W., Arany, P.R. and Philip, A. (2013) Transforming Growth Factor Beta Signaling in Cutaneous Wound Healing: Lessons Learned from Animal Studies. Advances in Wound Care (New Rochelle), 2, 225-237.
[41] Denis, J.F., Lévesque, M., Tran, S.D., Camarda, A.J. and Roy, S. (2013) Axolotl as a Model to Study Scarless Wound Healing in Vertebrates: Role of the Transforming Growth Factor Beta Signaling Pathway. Advances in Wound Care (New Rochelle), 2, 250-260.
[42] Chen, W., Fu, X., Ge, S., Sun, T.Z., Zhou, G., Jiang, D.Y. and Sheng, Z.Y. (2005) Ontogeny of Expression of Transforming Growth Factor-Beta and Its Receptors and Their Possible Relationship with Scarless Healing in Human Fetal Skin. Wound Repair and Regeneration, 13, 68-75.
[43] Durani, P., Occleston, N., O’Kane, S. and Ferguson, M.W. (2008) Avotermin: A Novel Antiscarring Agent. International Journal of Lower Extremity Wounds, 7, 160-168.
[44] Finnson, K.W., McLean, S., Di Guglielmo, G.M. and Philip, A. (2013) Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring. Advances in Wound Care (New Rochelle), 2, 195-214.
[45] Singer, A.J., Huang, S.S., Huang, J.S., McClain, S.A., Romanov, A., Rooney, J. and Zimmerman, T. (2009) A Novel TGF-Beta Antagonist Speeds Reepithelialization and Reduces Scarring of Partial Thickness Porcine Burns. Journal of Burn Care & Research, 30, 329-334.
[46] Occleston, N.L., Laverty, H.G., O’Kane, S. and Ferguson, M.W. (2008) Prevention and Reduction of Scarring in the Skin by Transforming Growth Factor β 3 (TGFβ3): From Laboratory Discovery to Clinical Pharmaceutical. Journal of Biomaterials Science, Polymer Edition, 19, 1047-1063.
[47] Mann, A., Niekisch, K., Schirmacher, P. and Blessing, M. (2006) Granulocyte-Macrophage Colony-Stimulating Factor Is Essential for Normal Wound Healing. Journal of Investigative Dermatology Symposium Proceedings, 11, 87-92.
[48] Hu, X., Sun, H., Han, C.M., Wang, X.G. and Yu, W.J. (2011) Topically Applied rhGM-CSF for the Wound Healing: A Systematic Review. Burns, 37, 729-741.
[49] Yao, C., Yao, P., Wu, H. and Zha, Z.G. (2006) Acceleration of Wound Healing in Traumatic Ulcers by Absorbable Collagen Sponge Containing Recombinant Basic Fibroblast Growth Factor. Biomedical Materials, 1, 33-37.
[50] Hanft, J.R., Pollak, R.A., Barbul, A., van Gils, C., Kwon, P.S., Gray, S.M., Lynch, C.J., Semba, C.P. and Breen, T.J. (2008) Phase I Trial on the Safety of Topical rhVEGF on Chronic Neuropathic Diabetic Foot Ulcers. Journal of Wound Care, 17, 30-32, 34-37.
[51] Ferguson, M.W., Duncan, J., Bond, J., Bush, J., Durani, P., So, K., Taylor, L., Chantrey, J., Mason, T., James, G., Laverty, H., Occleston, N.L., Sattar, A., Ludlow, A. and O’Kane, S. (2009) Prophylactic Administration of Avotermin for Improvement of Skin Scarring: Three Double-Blind, Placebo-Controlled, Phase I/II Studies. Lancet, 373, 1264- 1274.
[52] Tuyet, H.L., Nguyen Quynh, T.T., Vo Hoang Minh, H., Thi Bich, D.N., Do Dinh, T., Le Tan, D., Van, H.L., Le Huy, T., Doan Huu, H. and Tran Trong, T.N. (2009) The Efficacy and Safety of Epidermal Growth Factor in Treatment of Diabetic Foot Ulcers: The Preliminary Results. International Wound Journal, 6, 159-166.
[53] Uchi, H., Igarashi, A., Urabe, K., Koga, T., Nakayama, J., Kawamori, R., Tamaki, K., Hirakata, H., Ohura, T. and Furue, M. (2009) Clinical Efficacy of Basic Fibroblast Growth Factor (bFGF) for Diabetic Ulcer. European Journal of Dermatology, 19, 461-468.
[54] So, K., McGrouther, D.A., Bush, J.A., Durani, P., Taylor, L., Skotny, G., Mason, T., Metcalfe, A., O’kane, S. and Ferguson, M.W. (2011) Avotermin for Scar Improvement Following Scar Revision Surgery: A Randomized, Double- Blind, Within-Patient, Placebo-Controlled, Phase II Clinical Trial. Plastic & Reconstructive Surgery, 128, 163-172.
[55] Bush, J., Duncan, J.A., Bond, J.S., Durani, P., So, K., Mason, T., O’Kane, S. and Ferguson, M.W. (2010) Scar-Improving Efficacy of Avotermin Administered into the Wound Margins of Skin Incisions as Evaluated by a Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial. Plastic & Reconstructive Surgery, 126, 1604-1615.
[56] McCollum, P.T., Bush, J.A., James, G., Mason, T., O’Kane, S., McCollum, C., Krievins, D., Shiralkar, S. and Ferguson, M.W. (2011) Randomized Phase II Clinical Trial of Avotermin versus Placebo for Scar Improvement. British Journal of Surgery, 98, 925-934.
[57] Hayashida, K. and Akita, S. (2012) Quality of Pediatric Second-Degree Burn Wound Scars Following the Application of Basic Fibroblast Growth Factor: Results of a Randomized, Controlled Pilot Study. Ostomy/Wound Management, 58, 32-36.
[58] Gil, E.S., Panilaitis, B., Bellas, E. and Kaplan, D.L. (2013) Functionalized Silk Biomaterials for Wound Healing. Advanced Healthcare Materials, 2, 206-217.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.